Related Experiment Video
Updated: Apr 28, 2026

Translational Orthotopic Models of Glioblastoma Multiforme
Published on: February 17, 2023
Protein tyrosine phosphatase receptor U (PTPRU) is required for glioma growth and motility
Zhichuan Zhu1, Yongjie Liu1, Kui Li1
1School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China, Department of Neurosurgery, Shanghai Neurosurgical Center, Huashan Hospital, Fudan University, Shanghai 200030, China and Institute of Neuroscience, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China.
Abstract:
The membrane protein tyrosine phosphatase receptor U (PTPRU) has been shown to function as a negative regulator of adhesion and proliferation in certain cancer cell types, primarily through its dephosphorylation of β-catenin and inhibition of subsequent downstream signaling. In the present study, we set out to characterize the role of PTPRU in glioma and found that, while the expression of full-length PTPRU protein is low in these tumors, a number of non-full-length PTPRU isoforms are highly expressed. Among these isoforms, one in particular is localized to the nucleus, and its expression is increased in glioma tissues in a manner that positively correlates with malignancy grade. Short hairpin RNA knockdown of endogenous PTPRU in human and rat glioma cell lines suppressed proliferation, survival, invasion, migration, adhesion and vasculogenic tube formation in vitro, as well as intracranial tumor progression in vivo. In addition, knocking down PTPRU reduced tyrosine phosphorylation (pY) and transcriptional activity of β-catenin, and we were able to specifically rescue the cell migration defect by expressing a LEF1-β-catenin fusion protein in PTPRU-depleted cells. PTPRU knockdown also led to increased tyrosine pY of the E3 ubiquitin ligase c-Cbl and to the destabilization of several focal adhesion proteins. Taken together, our findings demonstrate that endogenous PTPRU promote glioma progression through their effect on β-catenin and focal adhesion signaling.
Insights
The protein tyrosine phosphatase receptor U (PTPRU) promotes glioma progression by affecting beta-catenin and focal adhesion signaling. Knockdown of PTPRU suppressed tumor growth and spread in preclinical models.
Area of Science:
- Neuro-oncology
- Molecular biology
- Cancer research
Background:
- The protein tyrosine phosphatase receptor U (PTPRU) typically inhibits cancer cell adhesion and proliferation.
- Its role in glioma, a primary brain tumor, remains largely uncharacterized.
Purpose of the Study:
- To investigate the function and expression of PTPRU and its isoforms in glioma.
- To determine the impact of PTPRU on glioma cell behavior and tumor progression.
Main Methods:
- Analysis of PTPRU expression in glioma tissues and cell lines.
- Short hairpin RNA (shRNA) mediated knockdown of PTPRU in vitro and in vivo.
- Assessment of cell proliferation, survival, invasion, migration, adhesion, and tube formation.
- Evaluation of beta-catenin and c-Cbl phosphorylation and transcriptional activity.
- Analysis of focal adhesion protein stability.
Main Results:
- Non-full-length PTPRU isoforms, particularly nuclear-localized ones, are highly expressed in glioma and correlate with malignancy grade.
- PTPRU knockdown inhibited glioma cell proliferation, survival, invasion, migration, adhesion, and vasculogenic tube formation in vitro.
- PTPRU knockdown suppressed intracranial tumor progression in vivo.
- PTPRU depletion reduced beta-catenin tyrosine phosphorylation and transcriptional activity, and increased c-Cbl tyrosine phosphorylation.
- PTPRU knockdown led to destabilization of focal adhesion proteins.
Conclusions:
- Endogenous PTPRU promotes glioma progression through its influence on beta-catenin and focal adhesion signaling pathways.
- Targeting PTPRU may represent a novel therapeutic strategy for glioma.
More Related Videos
12:52Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
Published on: November 28, 2015
10:13Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
Published on: August 12, 2014
Related Concept Videos
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Receptor Tyrosine Kinases
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...